← Back
$LTRN All transactions

Lantern Pharma Inc.

D

$ Value

$0

Shares

3,200

Price

$0

Filed

Sep 23

Insider

Name

Silberstein David S.

Title

CIK

0001812659

Roles

Director

Transaction Details

Transaction Date

2021-11-04

Code

D

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

The two reported transactions involve an amendment of an outstanding option for purposes of reducing the option exercise price, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on June 15, 2020 and provides for vesting in equal monthly increments over a 36-month period commencing July 15, 2020. | The two reported transactions involve an amendment of an outstanding option for purposes of reducing the option exercise price, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on November 4, 2021 and provides for vesting in equal monthly increments over a 36-month period commencing December 4, 2021.

Filing Info

Accession No.

0001493152-25-014611

Form Type

4

Issuer CIK

0001763950

Silberstein David S.'s History

Date Ticker Type Value
2021-11-04 LTRN D $0
2021-11-04 LTRN A $0
2020-06-15 LTRN D $0
2020-06-15 LTRN A $0

Other Insiders at LTRN (90d)

No other insider activity at this issuer in the last 90 days.